Protocol for updating the cancer registry-based
European High Resolution Project
European High resolution (HR) studies on breast, colorectal, prostate, testis and stomach cancer carried out during the past years demonstrated that at least some European Cancer Registries (CRs) are able to collect clinical information on stage, diagnostic exams, treatment and follow-up, additionally to the routinely collected CR data.
The GENERAL AIM of the present HR study, as in the past, is to help interpreting differences in cancer outcome and survival across European populations, using more detailed data on diagnosis, treatment and follow-up than those usually available in the routine activity of cancer registries.
Short term aims
- to analyse patterns of care and adhesion to clinical recommendations and internationally agreed guidelines for diagnosis and treatment across countries, regions, or groups of patients
- to investigate disease-free and short term survival
- to increase the quality of data collected by CRs on stage and morphology, and to better characterize cancers, by means of validated biomarkers
- to test the feasibility of collecting data on co-morbidity potentially influencing cancer prognosis
Medium and long term aims
- to update follow-up for life status and relapse, after an adequate length of time since diagnosis. For this purpose, in addition to the usual procedures adopted by CRs to update life status and relapse, the linkage of the HR records with those included in the EUROCARE basic database will be carried out
The full study protocols are available here:
Summary High Resolution protocol final (update 27/01/2014)
Protocol High Resolution (update 10/08/2014), Annex A, Annex B, Annex C
Protocol High Resolution Comments & Note (update 10/08/2014)
Eurocare
EUROCARE-5